I want to help find it.
Neovascular age-related macular degeneration, also called wet AMD, is a chronic eye disorder that causes blurred vision or a blind spot in your visual field. It's generally caused by abnormal blood vessels that leak fluid or blood into the macula. The macula is in the part of the retina responsible for central vision.
The ALTISSIMO study is recruiting adults who have been diagnosed with wet AMD. The study is evaluating an investigational drug that could potentially be administered to wet AMD patients as an injection every 6 months. The study will compare this investigational product to a current standard of care treatment injected every 2 months.
Is study participation an option for me?
You may be eligible for the ALTISSIMO study if you:
Full study participation includes about 15 visits to a study center for screening, treatments, and assessments and is expected to last up to approximately 13 months.
- Are at least 50 years of age
- Have been diagnosed with wet AMD
- Meet additional requirements as determined by a screening process
To learn more about the ALTISSIMO study and to see if you may qualify to participate, visit www.altissimostudy.com.